首页> 外文会议>IEEE International Conference on E-Health and Bioengineering >Antiangiogenic and antiproliferative effects of halotolerant Penicillium chrysogenum var. chrysogenum on the human umbilical vein endothelial cells (HUVECs)
【24h】

Antiangiogenic and antiproliferative effects of halotolerant Penicillium chrysogenum var. chrysogenum on the human umbilical vein endothelial cells (HUVECs)

机译:Halotolerant penicillium rhrysogenum变化的抗血管生成和抗增殖作用。人脐静脉内皮细胞(Huvecs)上的蛹

获取原文

摘要

Inhibitors of angiogenesis have been currently developed which offer the hope of new treatment options such as diabetic retinopathy, psoriasis, rheumatoid arthritis and cancer. In this study was to investigate the antiproliferative and antiangiogenic effects of ethylacetate extract of Penicillium chrysogenum var. chrysogenum on the HUVECs. Real-time cell analysis system was used to analyze antiproliferative and antiangiogenic effects according to change of cell index values. In our study different concentrations of extract for cell prolifetation analysis were investigated. Antiangiogenic effect was evaluated according to invasion and migration activity. Antiproliferative effects of extract were increased on HUVECs according to concentration and time depending. IC50 concentration was analyzed as 78.97µg/mL on 72h. In the invasion and migration assays, 50µg/mL extract concentration significantly suppressed angiogenic responses. This finding suggests that extract be potentially more pharmacologically active. According to these results natural antioxidants gained from fungi are very essential resources in terms of biotechnology.
机译:目前已经开发出血管生成的抑制剂,其提出了新的治疗选择,例如糖尿病视网膜病变,牛皮癣,类风湿性关节炎和癌症。在该研究中,研究了甲基甲酸甲酸求解的抗增殖和抗膨化作用。 Huvecs上的Chrysogenum。实时细胞分析系统用于根据细胞指数值的变化分析抗增殖和抗血管生成效应。在我们研究中,研究了不同浓度的细胞增殖分析提取物。根据入侵和迁移活动评估抗血管生成效果。根据浓度和时间根据浓度和时间,提取物的抗增殖效果增加。在72h上分析IC50浓度为78.97μg/ ml。在侵袭和迁移测定中,50μg/ mL提取物浓度显着抑制血管生成反应。该发现表明,提取物可能更具药理学活跃。根据这些结果,从真菌中获得的天然抗氧化剂在生物技术方面是非常重要的资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号